4/A: LifeStance Health Group CFO Receives 362,844 Restricted Stock Units

Ryan McGroarty, CFO of LifeStance Health Group, received 362,844 restricted stock units (RSUs) on March 17, 2025, according to an amended SEC Form 4/A filing.

Summary

• Ryan McGroarty, the Chief Financial Officer and Treasurer of LifeStance Health Group, Inc., received 362,844 restricted stock units (RSUs) on March 17, 2025.
• Each RSU represents a contingent right to receive one share of LifeStance Health Group's common stock.
• An amended SEC Form 4/A was filed on March 26, 2025, to correct a previous filing that incorrectly reported the award as stock options instead of RSUs.
• The amended filing also updates the number of shares reported as securities beneficially owned following the transaction.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to executive compensation. It's neither particularly positive nor negative, but reflects standard corporate governance practices.

Positives

• The grant of RSUs to the CFO could be seen as an incentive to align his interests with those of the shareholders.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Comparing the size of the RSU grant to similar companies in the behavioral health sector would provide context on whether the grant is within industry norms.
• Companies like Teladoc Health or Amwell could be used as benchmarks for executive compensation structures.

Stakeholder Impact

• The RSU grant could potentially impact shareholder value depending on the future performance of the company.

Key Dates

Keywords

LifeStance Health Group, Ryan McGroarty, Restricted Stock Units, RSUs, SEC Form 4, Beneficial Ownership, CFO, LFST